nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—chronic obstructive pulmonary disease	0.675	1	CbGaD
Octreotide—SSTR4—respiratory system—chronic obstructive pulmonary disease	0.00112	0.543	CbGeAlD
Octreotide—MPO—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000425	0.00423	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000424	0.00423	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.000424	0.00422	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000421	0.0042	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000421	0.00419	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000416	0.00415	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00041	0.00409	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000408	0.00407	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000406	0.00404	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000405	0.00404	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—TNF—chronic obstructive pulmonary disease	0.000398	0.00396	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000391	0.0039	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000389	0.00388	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000389	0.00387	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000388	0.00386	CbGpPWpGaD
Octreotide—SSTR1—lung—chronic obstructive pulmonary disease	0.000383	0.186	CbGeAlD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000374	0.00372	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000373	0.00371	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00037	0.00368	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000367	0.00365	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000365	0.00363	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000357	0.00356	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00035	0.00348	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000348	0.00346	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000347	0.00346	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000345	0.00344	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000345	0.00344	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000338	0.00336	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000337	0.00336	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000336	0.00334	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000333	0.00332	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00033	0.00329	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000327	0.00326	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000325	0.00323	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.000321	0.0032	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000321	0.00319	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00032	0.00319	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000319	0.00318	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000319	0.00317	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000317	0.00315	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000317	0.00315	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000316	0.00314	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000311	0.0031	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00031	0.00309	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000308	0.00307	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000306	0.00305	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000303	0.00301	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000298	0.00297	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000295	0.00294	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000294	0.00293	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000292	0.00291	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000286	0.00285	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000282	0.00281	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00028	0.00279	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000278	0.00277	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000274	0.00273	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000273	0.00272	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000271	0.0027	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00027	0.00269	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000269	0.00267	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000268	0.00267	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000268	0.00267	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000266	0.00265	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000264	0.00263	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00026	0.00259	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000259	0.00258	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000254	0.00253	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000251	0.00249	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00025	0.00249	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00025	0.00249	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000248	0.00247	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000248	0.00247	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000248	0.00247	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000246	0.00245	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000246	0.00245	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000244	0.00243	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000244	0.00243	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000243	0.00242	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000238	0.00237	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000238	0.00237	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000236	0.00235	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000236	0.00235	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000233	0.00232	CbGpPWpGaD
Octreotide—MPO—respiratory system—chronic obstructive pulmonary disease	0.000232	0.113	CbGeAlD
Octreotide—SSTR4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000232	0.00231	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000231	0.0023	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00023	0.00229	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000221	0.0022	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00022	0.00219	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000219	0.00218	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000218	0.00217	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000216	0.00215	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000211	0.0021	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000211	0.0021	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000209	0.00208	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000207	0.00206	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000207	0.00206	CbGpPWpGaD
Octreotide—MPO—connective tissue—chronic obstructive pulmonary disease	0.000204	0.0991	CbGeAlD
Octreotide—MPO—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000202	0.00201	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.0002	0.00199	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000199	0.00198	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000198	0.00197	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000198	0.00197	CbGpPWpGaD
Octreotide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000885	CcSEcCtD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000197	0.00196	CbGpPWpGaD
Octreotide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.000884	CcSEcCtD
Octreotide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000882	CcSEcCtD
Octreotide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000196	0.000881	CcSEcCtD
Octreotide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.000881	CcSEcCtD
Octreotide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.00088	CcSEcCtD
Octreotide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00088	CcSEcCtD
Octreotide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00088	CcSEcCtD
Octreotide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000195	0.000877	CcSEcCtD
Octreotide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.000877	CcSEcCtD
Octreotide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.000874	CcSEcCtD
Octreotide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000195	0.000874	CcSEcCtD
Octreotide—SSTR2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000195	0.00194	CbGpPWpGaD
Octreotide—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000873	CcSEcCtD
Octreotide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000873	CcSEcCtD
Octreotide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000873	CcSEcCtD
Octreotide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000194	0.00087	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000193	0.00192	CbGpPWpGaD
Octreotide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.000866	CcSEcCtD
Octreotide—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000864	CcSEcCtD
Octreotide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000192	0.000863	CcSEcCtD
Octreotide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000192	0.000862	CcSEcCtD
Octreotide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000861	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000191	0.0019	CbGpPWpGaD
Octreotide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000855	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000189	0.00188	CbGpPWpGaD
Octreotide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000848	CcSEcCtD
Octreotide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000848	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000188	0.00187	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000188	0.00187	CbGpPWpGaD
Octreotide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000843	CcSEcCtD
Octreotide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000839	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000186	0.00186	CbGpPWpGaD
Octreotide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.000835	CcSEcCtD
Octreotide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000835	CcSEcCtD
Octreotide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000834	CcSEcCtD
Octreotide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.000832	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000185	0.00185	CbGpPWpGaD
Octreotide—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000831	CcSEcCtD
Octreotide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.000828	CcSEcCtD
Octreotide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000827	CcSEcCtD
Octreotide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000824	CcSEcCtD
Octreotide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.00082	CcSEcCtD
Octreotide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00082	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000819	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000819	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000181	0.00181	CbGpPWpGaD
Octreotide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000181	0.000813	CcSEcCtD
Octreotide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.000813	CcSEcCtD
Octreotide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.000809	CcSEcCtD
Octreotide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00018	0.000808	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000179	0.00178	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000179	0.000802	CcSEcCtD
Octreotide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000179	0.000801	CcSEcCtD
Octreotide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.000801	CcSEcCtD
Octreotide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000799	CcSEcCtD
Octreotide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000799	CcSEcCtD
Octreotide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000177	0.000796	CcSEcCtD
Octreotide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000793	CcSEcCtD
Octreotide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000791	CcSEcCtD
Octreotide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000791	CcSEcCtD
Octreotide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00079	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000176	0.00175	CbGpPWpGaD
Octreotide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.000788	CcSEcCtD
Octreotide—Injury—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000783	CcSEcCtD
Octreotide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000782	CcSEcCtD
Octreotide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.000781	CcSEcCtD
Octreotide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000779	CcSEcCtD
Octreotide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000776	CcSEcCtD
Octreotide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000776	CcSEcCtD
Octreotide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000173	0.000775	CcSEcCtD
Octreotide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000775	CcSEcCtD
Octreotide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000775	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000773	CcSEcCtD
Octreotide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000768	CcSEcCtD
Octreotide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000768	CcSEcCtD
Octreotide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000768	CcSEcCtD
Octreotide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000768	CcSEcCtD
Octreotide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.000767	CcSEcCtD
Octreotide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000766	CcSEcCtD
Octreotide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000762	CcSEcCtD
Octreotide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00076	CcSEcCtD
Octreotide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000759	CcSEcCtD
Octreotide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000756	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000168	0.00168	CbGpPWpGaD
Octreotide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000754	CcSEcCtD
Octreotide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000753	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000168	0.00167	CbGpPWpGaD
Octreotide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.000751	CcSEcCtD
Octreotide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000748	CcSEcCtD
Octreotide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.000747	CcSEcCtD
Octreotide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.000744	CcSEcCtD
Octreotide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.000744	CcSEcCtD
Octreotide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000742	CcSEcCtD
Octreotide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00074	CcSEcCtD
Octreotide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00074	CcSEcCtD
Octreotide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.00074	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000165	0.00164	CbGpPWpGaD
Octreotide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000737	CcSEcCtD
Octreotide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.000736	CcSEcCtD
Octreotide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000164	0.000735	CcSEcCtD
Octreotide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.000735	CcSEcCtD
Octreotide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000732	CcSEcCtD
Octreotide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000731	CcSEcCtD
Octreotide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000725	CcSEcCtD
Octreotide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000725	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000161	0.0016	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00072	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000719	CcSEcCtD
Octreotide—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000719	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00016	0.00159	CbGpPWpGaD
Octreotide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000714	CcSEcCtD
Octreotide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000714	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000159	0.00158	CbGpPWpGaD
Octreotide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00071	CcSEcCtD
Octreotide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00071	CcSEcCtD
Octreotide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00071	CcSEcCtD
Octreotide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00071	CcSEcCtD
Octreotide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.000708	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000157	0.00156	CbGpPWpGaD
Octreotide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000703	CcSEcCtD
Octreotide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.000702	CcSEcCtD
Octreotide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.000701	CcSEcCtD
Octreotide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.000701	CcSEcCtD
Octreotide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000699	CcSEcCtD
Octreotide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000699	CcSEcCtD
Octreotide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.000697	CcSEcCtD
Octreotide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000697	CcSEcCtD
Octreotide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000696	CcSEcCtD
Octreotide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000696	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000155	0.00154	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000694	CcSEcCtD
Octreotide—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000687	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000153	0.00152	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000152	0.00151	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000151	0.0015	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00015	0.0015	CbGpPWpGaD
Octreotide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000674	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00015	0.0015	CbGpPWpGaD
Octreotide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000671	CcSEcCtD
Octreotide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000671	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000149	0.00149	CbGpPWpGaD
Octreotide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000662	CcSEcCtD
Octreotide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000662	CcSEcCtD
Octreotide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000661	CcSEcCtD
Octreotide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00066	CcSEcCtD
Octreotide—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000659	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000146	0.00146	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000145	0.00144	CbGpPWpGaD
Octreotide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000648	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000144	0.00143	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000144	0.00143	CbGpPWpGaD
Octreotide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.000645	CcSEcCtD
Octreotide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000144	0.000645	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000143	0.00142	CbGpPWpGaD
Octreotide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000636	CcSEcCtD
Octreotide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000636	CcSEcCtD
Octreotide—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000635	CcSEcCtD
Octreotide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000631	CcSEcCtD
Octreotide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000626	CcSEcCtD
Octreotide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000625	CcSEcCtD
Octreotide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000623	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000138	0.00137	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000137	0.00137	CbGpPWpGaD
Octreotide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000615	CcSEcCtD
Octreotide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000615	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000137	0.00136	CbGpPWpGaD
Octreotide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000612	CcSEcCtD
Octreotide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00061	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000136	0.00135	CbGpPWpGaD
Octreotide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000609	CcSEcCtD
Octreotide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000606	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000135	0.00134	CbGpPWpGaD
Octreotide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000602	CcSEcCtD
Octreotide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.0006	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000134	0.00133	CbGpPWpGaD
Octreotide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000596	CcSEcCtD
Octreotide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.000594	CcSEcCtD
Octreotide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000132	0.000594	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000132	0.00131	CbGpPWpGaD
Octreotide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00013	0.000582	CcSEcCtD
Octreotide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00058	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000128	0.00127	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000128	0.00127	CbGpPWpGaD
Octreotide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000571	CcSEcCtD
Octreotide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000571	CcSEcCtD
Octreotide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000567	CcSEcCtD
Octreotide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000567	CcSEcCtD
Octreotide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000566	CcSEcCtD
Octreotide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000566	CcSEcCtD
Octreotide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000566	CcSEcCtD
Octreotide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000125	0.000563	CcSEcCtD
Octreotide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.000563	CcSEcCtD
Octreotide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000563	CcSEcCtD
Octreotide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000562	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000125	0.00125	CbGpPWpGaD
Octreotide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000561	CcSEcCtD
Octreotide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000561	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000125	0.00124	CbGpPWpGaD
Octreotide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00056	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000124	0.00124	CbGpPWpGaD
Octreotide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000555	CcSEcCtD
Octreotide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000554	CcSEcCtD
Octreotide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000553	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000123	0.00123	CbGpPWpGaD
Octreotide—MPO—lung—chronic obstructive pulmonary disease	0.000123	0.0598	CbGeAlD
Octreotide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000553	CcSEcCtD
Octreotide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000123	0.000551	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000121	0.00121	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000543	CcSEcCtD
Octreotide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000539	CcSEcCtD
Octreotide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000538	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00012	0.00119	CbGpPWpGaD
Octreotide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000536	CcSEcCtD
Octreotide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000535	CcSEcCtD
Octreotide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000535	CcSEcCtD
Octreotide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000534	CcSEcCtD
Octreotide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000534	CcSEcCtD
Octreotide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000534	CcSEcCtD
Octreotide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000531	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000118	0.00117	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000118	0.00117	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000117	0.00116	CbGpPWpGaD
Octreotide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000524	CcSEcCtD
Octreotide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000523	CcSEcCtD
Octreotide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000517	CcSEcCtD
Octreotide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000515	CcSEcCtD
Octreotide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000507	CcSEcCtD
Octreotide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000504	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000112	0.00112	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000112	0.00111	CbGpPWpGaD
Octreotide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000502	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000111	0.00111	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.00011	0.00109	CbGpPWpGaD
Octreotide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000487	CcSEcCtD
Octreotide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000487	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000108	0.00107	CbGpPWpGaD
Octreotide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000479	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000106	0.00106	CbGpPWpGaD
Octreotide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000475	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000105	0.00105	CbGpPWpGaD
Octreotide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00047	CcSEcCtD
Octreotide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000462	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000102	0.00102	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000102	0.00101	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000101	0.00101	CbGpPWpGaD
Octreotide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00045	CcSEcCtD
Octreotide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000445	CcSEcCtD
Octreotide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.81e-05	0.00044	CcSEcCtD
Octreotide—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.8e-05	0.00044	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.79e-05	0.000975	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.79e-05	0.000975	CbGpPWpGaD
Octreotide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.74e-05	0.000437	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.72e-05	0.000968	CbGpPWpGaD
Octreotide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000436	CcSEcCtD
Octreotide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000433	CcSEcCtD
Octreotide—Erythema—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000433	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.43e-05	0.000939	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.34e-05	0.00093	CbGpPWpGaD
Octreotide—Pain—Prednisolone—chronic obstructive pulmonary disease	9.27e-05	0.000416	CcSEcCtD
Octreotide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000408	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.04e-05	0.0009	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.04e-05	0.0009	CbGpPWpGaD
Octreotide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000402	CcSEcCtD
Octreotide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.94e-05	0.000401	CcSEcCtD
Octreotide—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.0004	CcSEcCtD
Octreotide—Agitation—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.000398	CcSEcCtD
Octreotide—Malaise—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000391	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.69e-05	0.000865	CbGpPWpGaD
Octreotide—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.67e-05	0.000389	CcSEcCtD
Octreotide—Syncope—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000389	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.62e-05	0.000859	CbGpPWpGaD
Octreotide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.61e-05	0.000387	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.49e-05	0.000845	CbGpPWpGaD
Octreotide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000381	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.42e-05	0.000839	CbGpPWpGaD
Octreotide—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000375	CcSEcCtD
Octreotide—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000374	CcSEcCtD
Octreotide—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000369	CcSEcCtD
Octreotide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000369	CcSEcCtD
Octreotide—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.000368	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.16e-05	0.000366	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.14e-05	0.00081	CbGpPWpGaD
Octreotide—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000364	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.08e-05	0.000804	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.02e-05	0.000798	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.02e-05	0.000798	CbGpPWpGaD
Octreotide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.99e-05	0.000358	CcSEcCtD
Octreotide—Oedema—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000354	CcSEcCtD
Octreotide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000354	CcSEcCtD
Octreotide—Infection—Prednisone—chronic obstructive pulmonary disease	7.83e-05	0.000351	CcSEcCtD
Octreotide—Shock—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000348	CcSEcCtD
Octreotide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000347	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.71e-05	0.000767	CbGpPWpGaD
Octreotide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000345	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.66e-05	0.000762	CbGpPWpGaD
Octreotide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000343	CcSEcCtD
Octreotide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000342	CcSEcCtD
Octreotide—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.51e-05	0.000337	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.43e-05	0.00074	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.4e-05	0.000737	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.39e-05	0.000736	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.37e-05	0.000734	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.34e-05	0.000731	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.22e-05	0.000719	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000322	CcSEcCtD
Octreotide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000322	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.16e-05	0.000713	CbGpPWpGaD
Octreotide—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.00032	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.09e-05	0.000706	CbGpPWpGaD
Octreotide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000318	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.07e-05	0.000704	CbGpPWpGaD
Octreotide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000311	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.85e-05	0.000682	CbGpPWpGaD
Octreotide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000307	CcSEcCtD
Octreotide—Rash—Prednisolone—chronic obstructive pulmonary disease	6.84e-05	0.000307	CcSEcCtD
Octreotide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.83e-05	0.000307	CcSEcCtD
Octreotide—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000305	CcSEcCtD
Octreotide—Headache—Prednisolone—chronic obstructive pulmonary disease	6.79e-05	0.000305	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.77e-05	0.000674	CbGpPWpGaD
Octreotide—Constipation—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000302	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.66e-05	0.000663	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.61e-05	0.000658	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.57e-05	0.000654	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.55e-05	0.000653	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.51e-05	0.000648	CbGpPWpGaD
Octreotide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000291	CcSEcCtD
Octreotide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000289	CcSEcCtD
Octreotide—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000289	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.27e-05	0.000624	CbGpPWpGaD
Octreotide—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000281	CcSEcCtD
Octreotide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.00028	CcSEcCtD
Octreotide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.00028	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.05e-05	0.000602	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.01e-05	0.000598	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.01e-05	0.000598	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.83e-05	0.00058	CbGpPWpGaD
Octreotide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000261	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.78e-05	0.000576	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.71e-05	0.000569	CbGpPWpGaD
Octreotide—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000254	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.63e-05	0.000561	CbGpPWpGaD
Octreotide—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.58e-05	0.00025	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.43e-05	0.000541	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.4e-05	0.000538	CbGpPWpGaD
Octreotide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.000242	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.38e-05	0.000535	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.38e-05	0.000535	CbGpPWpGaD
Octreotide—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000234	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.15e-05	0.000513	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.13e-05	0.000511	CbGpPWpGaD
Octreotide—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000225	CcSEcCtD
Octreotide—Rash—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000223	CcSEcCtD
Octreotide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.000223	CcSEcCtD
Octreotide—Headache—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000222	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.92e-05	0.00049	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.88e-05	0.000486	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.79e-05	0.000477	CbGpPWpGaD
Octreotide—Nausea—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.00021	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.57e-05	0.000455	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.55e-05	0.000453	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.48e-05	0.000446	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.42e-05	0.00044	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.39e-05	0.000437	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.36e-05	0.000435	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.36e-05	0.000435	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.33e-05	0.000431	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.22e-05	0.00042	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.15e-05	0.000413	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.12e-05	0.00041	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.03e-05	0.000401	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.95e-05	0.000393	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.87e-05	0.000386	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.7e-05	0.000368	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.69e-05	0.000367	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.68e-05	0.000367	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.57e-05	0.000356	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.55e-05	0.000353	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.5e-05	0.000349	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.4e-05	0.000338	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.39e-05	0.000338	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.37e-05	0.000336	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.33e-05	0.000331	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.25e-05	0.000324	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.23e-05	0.000322	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.19e-05	0.000318	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.14e-05	0.000313	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.9e-05	0.000289	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.89e-05	0.000287	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.83e-05	0.000282	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.79e-05	0.000278	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.68e-05	0.000267	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.66e-05	0.000265	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.61e-05	0.00026	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.56e-05	0.000255	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.45e-05	0.000244	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.38e-05	0.000237	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.19e-05	0.000218	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.17e-05	0.000217	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.01e-05	0.0002	CbGpPWpGaD
